ReP USP - Resultado da busca

Artigo de periodico
Extracellular vesicle derived from neural stem cells as potential vehicles of genetic information to modulate glioblastoma biology (2023)
Araújo, João Pedro Alves de ; Cruz, Lilian; Souza, Maria Clara da Silva ; Prado, Mariana Brandão ; Alves, Rodrigo Nunes ; Coelho, Bárbara Paranhos ; Soares, Samuel Ribeiro; Fernandes, Camila Felix ; Lopes, Marilene Hohmuth
Fonte: Cancer Research. Nome do evento: Proceedings: American Association Cancer Research. Annual Meeting. Unidade: ICB
Assuntos: CÉLULAS CULTIVADAS DE TUMOR, GLIOMA, ASTROCITOMA, NEOPLASIAS CEREBRAIS, CÉLULAS-TRONCO, WESTERN BLOTTING, IMUNOFLUORESCÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, João Pedro Alves de et al. Extracellular vesicle derived from neural stem cells as potential vehicles of genetic information to modulate glioblastoma biology. Cancer Research, v. 83, n. Abstract 3661, 2023Tradução . . Disponível em: https://doi.org/10.1158/1538-7445.AM2023-3661. Acesso em: 10 nov. 2024.
APA
Araújo, J. P. A. de, Cruz, L., Souza, M. C. da S., Prado, M. B., Alves, R. N., Coelho, B. P., et al. (2023). Extracellular vesicle derived from neural stem cells as potential vehicles of genetic information to modulate glioblastoma biology. Cancer Research, 83( Abstract 3661). doi:10.1158/1538-7445.AM2023-3661
NLM
Araújo JPA de, Cruz L, Souza MC da S, Prado MB, Alves RN, Coelho BP, Soares SR, Fernandes CF, Lopes MH. Extracellular vesicle derived from neural stem cells as potential vehicles of genetic information to modulate glioblastoma biology [Internet]. Cancer Research. 2023 ; 83( Abstract 3661):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2023-3661
Vancouver
Araújo JPA de, Cruz L, Souza MC da S, Prado MB, Alves RN, Coelho BP, Soares SR, Fernandes CF, Lopes MH. Extracellular vesicle derived from neural stem cells as potential vehicles of genetic information to modulate glioblastoma biology [Internet]. Cancer Research. 2023 ; 83( Abstract 3661):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2023-3661
Artigo de periodico
The cellular prion protein is involved in the modulation of Wnt signaling in glioblastoma (2023)
Coelho, Bárbara Paranhos ; Prado, Mariana B. ; Ferreira, Frederico M. ; Santos, Tiago G.; Nakaya, Helder Takashi Imoto ; Lopes, Marilene Hohmuth
Fonte: Cancer Research. Nome do evento: Proceedings: American Association for Cancer Research Annual Meeting. Unidades: FCF, ICB
Assuntos: CÉLULAS CULTIVADAS DE TUMOR, GLIOMA, ASTROCITOMA, NEOPLASIAS CEREBRAIS, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Bárbara Paranhos et al. The cellular prion protein is involved in the modulation of Wnt signaling in glioblastoma. Cancer Research, v. 83, p. 325, 2023Tradução . . Disponível em: https://doi.org/10.1158/1538-7445.AM2023-325. Acesso em: 10 nov. 2024.
APA
Coelho, B. P., Prado, M. B., Ferreira, F. M., Santos, T. G., Nakaya, H. T. I., & Lopes, M. H. (2023). The cellular prion protein is involved in the modulation of Wnt signaling in glioblastoma. Cancer Research, 83, 325. doi:10.1158/1538-7445.AM2023-325
NLM
Coelho BP, Prado MB, Ferreira FM, Santos TG, Nakaya HTI, Lopes MH. The cellular prion protein is involved in the modulation of Wnt signaling in glioblastoma [Internet]. Cancer Research. 2023 ; 83 325.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2023-325
Vancouver
Coelho BP, Prado MB, Ferreira FM, Santos TG, Nakaya HTI, Lopes MH. The cellular prion protein is involved in the modulation of Wnt signaling in glioblastoma [Internet]. Cancer Research. 2023 ; 83 325.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2023-325
Trabalho de evento-resumo periodico
Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer (2022)
Chaves, Luiz Paulo; Caliari, André Luiz; Lautert-Dutra, William ; Silva, Francisco Cesar de Sousa e ; Melo, Camila Morais; Saggioro, Fabiano Pinto; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting. Unidade: FMRP
Assuntos: IMUNOLOGIA CELULAR, NEOPLASIAS, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Luiz Paulo et al. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2022-6098. Acesso em: 10 nov. 2024. , 2022
APA
Chaves, L. P., Caliari, A. L., Lautert-Dutra, W., Silva, F. C. de S. e, Melo, C. M., Saggioro, F. P., et al. (2022). Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2022-6098
NLM
Chaves LP, Caliari AL, Lautert-Dutra W, Silva FC de S e, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6098
Vancouver
Chaves LP, Caliari AL, Lautert-Dutra W, Silva FC de S e, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6098
Trabalho de evento-resumo periodico
DUSP6 modulates migration and glycolysis in PDAC cells (2022)
Ruckert, Mariana Tannús ; Bye, Bailey A.; VanSaun, Michael N.; Silveira, Vanessa da Silva
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting. Unidade: FMRP
Assuntos: CÉLULAS, ADENOCARCINOMA, PÂNCREAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUCKERT, Mariana Tannús et al. DUSP6 modulates migration and glycolysis in PDAC cells. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2022-157. Acesso em: 10 nov. 2024. , 2022
APA
Ruckert, M. T., Bye, B. A., VanSaun, M. N., & Silveira, V. da S. (2022). DUSP6 modulates migration and glycolysis in PDAC cells. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2022-157
NLM
Ruckert MT, Bye BA, VanSaun MN, Silveira V da S. DUSP6 modulates migration and glycolysis in PDAC cells [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-157
Vancouver
Ruckert MT, Bye BA, VanSaun MN, Silveira V da S. DUSP6 modulates migration and glycolysis in PDAC cells [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-157
Trabalho de evento-resumo periodico
Knockout of cellular prion protein in glioblastoma affects the expression of Wnt signaling genes (2022)
Coelho, Bárbara Paranhos ; Prado, Mariana Brandão ; Iglesia, Rebeca Piatniczka ; Escobar, Maria Isabel Melo ; Ferreira, Frederico Moraes ; Santos, Tiago Góss dos ; Nakaya, Helder Takashi Imoto ; Lopes, Marilene Hohmuth
Fonte: Cancer Research. Nome do evento: American Association for Cancer Research/AACR. Unidades: FM, ICB, FCF
Assuntos: NEOPLASIAS DO SISTEMA NERVOSO, PROLIFERAÇÃO CELULAR, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Bárbara Paranhos et al. Knockout of cellular prion protein in glioblastoma affects the expression of Wnt signaling genes. Cancer Research. Philadelphia: AACR. Disponível em: https://aacrjournals.org/cancerres/article/82/12_Supplement/103/701611. Acesso em: 10 nov. 2024. , 2022
APA
Coelho, B. P., Prado, M. B., Iglesia, R. P., Escobar, M. I. M., Ferreira, F. M., Santos, T. G. dos, et al. (2022). Knockout of cellular prion protein in glioblastoma affects the expression of Wnt signaling genes. Cancer Research. Philadelphia: AACR. Recuperado de https://aacrjournals.org/cancerres/article/82/12_Supplement/103/701611
NLM
Coelho BP, Prado MB, Iglesia RP, Escobar MIM, Ferreira FM, Santos TG dos, Nakaya HTI, Lopes MH. Knockout of cellular prion protein in glioblastoma affects the expression of Wnt signaling genes [Internet]. Cancer Research. 2022 ; 82( 12): 1-4.[citado 2024 nov. 10 ] Available from: https://aacrjournals.org/cancerres/article/82/12_Supplement/103/701611
Vancouver
Coelho BP, Prado MB, Iglesia RP, Escobar MIM, Ferreira FM, Santos TG dos, Nakaya HTI, Lopes MH. Knockout of cellular prion protein in glioblastoma affects the expression of Wnt signaling genes [Internet]. Cancer Research. 2022 ; 82( 12): 1-4.[citado 2024 nov. 10 ] Available from: https://aacrjournals.org/cancerres/article/82/12_Supplement/103/701611
Trabalho de evento-resumo periodico
Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort (2022)
Lautert-Dutra, William ; Melo, Camila Morais; Chaves, Luiz Paulo; Caliari, André Luiz; Silva, Francisco Cesar de Sousa e ; Squire, Jeremy Andrew
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting. Unidade: FMRP
Assuntos: EXPRESSÃO GÊNICA, NEOPLASIAS, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAUTERT-DUTRA, William et al. Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2022-6099. Acesso em: 10 nov. 2024. , 2022
APA
Lautert-Dutra, W., Melo, C. M., Chaves, L. P., Caliari, A. L., Silva, F. C. de S. e, & Squire, J. A. (2022). Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2022-6099
NLM
Lautert-Dutra W, Melo CM, Chaves LP, Caliari AL, Silva FC de S e, Squire JA. Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6099
Vancouver
Lautert-Dutra W, Melo CM, Chaves LP, Caliari AL, Silva FC de S e, Squire JA. Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6099
Trabalho de evento-resumo periodico
The evolutionary trajectory of epigenomics in adult glioma (2021)
Datta, Indrani; Pereira, Tathiane Maistro Malta; Sabedot, Thais Sarraf; She, Ruicong; Iavarone, Antonio; Noushmehr, Houtan; Poisson, Laila M.
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting 2021. Unidades: FCFRP, FMRP
Assuntos: GLIOMA, SISTEMA NERVOSO CENTRAL, DADOS DE SEQUÊNCIA MOLECULAR, GENOMAS, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DATTA, Indrani et al. The evolutionary trajectory of epigenomics in adult glioma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2085. Acesso em: 10 nov. 2024. , 2021
APA
Datta, I., Pereira, T. M. M., Sabedot, T. S., She, R., Iavarone, A., Noushmehr, H., & Poisson, L. M. (2021). The evolutionary trajectory of epigenomics in adult glioma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2085
NLM
Datta I, Pereira TMM, Sabedot TS, She R, Iavarone A, Noushmehr H, Poisson LM. The evolutionary trajectory of epigenomics in adult glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2085
Vancouver
Datta I, Pereira TMM, Sabedot TS, She R, Iavarone A, Noushmehr H, Poisson LM. The evolutionary trajectory of epigenomics in adult glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2085
Trabalho de evento-resumo periodico
Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma (2021)
Varn, Frederick; Johnson, Kevin C.; Barthel, Floris P.; Kim, Hoon; Wade, Taylor; Lodha, Disha; Ajaib, Shoaib; Ahmed, Nazia; Garofano, Luciano; D'Angelo, Fulvio; Stead, Lucy; Noushmehr, Houtan; Iavarone, Antonio; Verhaak, Roel
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting 2021. Unidade: FMRP
Assuntos: GLIOMA, DERIVA GÊNICA, SISTEMA IMUNE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARN, Frederick et al. Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2169. Acesso em: 10 nov. 2024. , 2021
APA
Varn, F., Johnson, K. C., Barthel, F. P., Kim, H., Wade, T., Lodha, D., et al. (2021). Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2169
NLM
Varn F, Johnson KC, Barthel FP, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D'Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2169
Vancouver
Varn F, Johnson KC, Barthel FP, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D'Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2169
Trabalho de evento-resumo periodico
Glioma immune microenvironment change during tumor recurrence (2021)
Pereira, Tathiane Maistro Malta; Datta, Indrani; Sabedot, Thais; She, Ruicong; Castro, Ana Valéria; Iavarone, Antonio; Poisson, Laila M.; Noushmehr, Houtan
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting 2021. Unidades: FCFRP, FMRP
Assuntos: GLIOMA, GENOMAS, METILAÇÃO DE DNA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Tathiane Maistro Malta et al. Glioma immune microenvironment change during tumor recurrence. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2717. Acesso em: 10 nov. 2024. , 2021
APA
Pereira, T. M. M., Datta, I., Sabedot, T., She, R., Castro, A. V., Iavarone, A., et al. (2021). Glioma immune microenvironment change during tumor recurrence. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2717
NLM
Pereira TMM, Datta I, Sabedot T, She R, Castro AV, Iavarone A, Poisson LM, Noushmehr H. Glioma immune microenvironment change during tumor recurrence [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2717
Vancouver
Pereira TMM, Datta I, Sabedot T, She R, Castro AV, Iavarone A, Poisson LM, Noushmehr H. Glioma immune microenvironment change during tumor recurrence [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2717
Trabalho de evento-resumo periodico
Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system (2021)
Pimentel, Franklin Fernandes; Buzatto, Isabela Panzeri Carlotti; Rodrigues, Tamara Cristina Gomes Ferraz; Borba, Jéssica Maria Camargo; Peruchi, Karoline P. I.; Andrade, Jurandyr Moreira de ; Tiezzi, Daniel Guimarães
Fonte: Cancer Research. Nome do evento: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, NEOPLASIAS MAMÁRIAS, MENOPAUSA, SISTEMA ÚNICO DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27. Acesso em: 10 nov. 2024. , 2021
APA
Pimentel, F. F., Buzatto, I. P. C., Rodrigues, T. C. G. F., Borba, J. M. C., Peruchi, K. P. I., Andrade, J. M. de, & Tiezzi, D. G. (2021). Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS9-27
NLM
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Vancouver
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Trabalho de evento-resumo periodico
ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer (2021)
Souza, Luiz Paulo Chaves; Costa, André Luiz Caliari ; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Squire, Jeremy Andrew
Fonte: Cancer Research. Nome do evento: Proceedings of the American Association for Cancer Research Annual Meeting. Unidades: SVOI, FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, MUTAÇÃO GENÉTICA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves et al. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-1818. Acesso em: 10 nov. 2024. , 2021
APA
Souza, L. P. C., Costa, A. L. C., Melo, C. M., Saggioro, F. P., & Squire, J. A. (2021). ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-1818
NLM
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Vancouver
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Artigo de periodico
A high-content screen identifies drugs that restrict tumor cell extravasation across the Endothelial Barrier (2021)
Hilfenhaus, Georg ; Mompeón, Ana ; Freshman, Jonathan ; Prajapati, Divya P. ; Hernandez, Gloria ; Freitas, Vanessa Morais ; Ma, Feiyang ; Langenbacher, Adam D. ; Mirkov, Snezana ; Song, Dana ; Cho, Byoung-Kyu ; Goo, Young Ah; Pellegrini, Matteo; Chen, Jau-Nian ; Damoiseaux, Robert ; Arispe, M. Luisa Iruela
Fonte: Cancer Research. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, METÁSTASE NEOPLÁSICA, CÉLULAS CULTIVADAS DE TUMOR, CÉLULAS ENDOTELIAIS, ANTINEOPLÁSICOS, INTERAÇÃO CELULAR, ENDOTÉLIO VASCULAR, PROLIFERAÇÃO CELULAR, NEOPLASIAS PULMONARES, CAMUNDONGOS ENDOGÂMICOS C57BL, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HILFENHAUS, Georg et al. A high-content screen identifies drugs that restrict tumor cell extravasation across the Endothelial Barrier. Cancer Research, v. 81, n. 3, p. 619-633, 2021Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.can-19-3911. Acesso em: 10 nov. 2024.
APA
Hilfenhaus, G., Mompeón, A., Freshman, J., Prajapati, D. P., Hernandez, G., Freitas, V. M., et al. (2021). A high-content screen identifies drugs that restrict tumor cell extravasation across the Endothelial Barrier. Cancer Research, 81( 3), 619-633. doi:10.1158/0008-5472.can-19-3911
NLM
Hilfenhaus G, Mompeón A, Freshman J, Prajapati DP, Hernandez G, Freitas VM, Ma F, Langenbacher AD, Mirkov S, Song D, Cho B-K, Goo YA, Pellegrini M, Chen J-N, Damoiseaux R, Arispe MLI. A high-content screen identifies drugs that restrict tumor cell extravasation across the Endothelial Barrier [Internet]. Cancer Research. 2021 ; 81( 3): 619-633.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/0008-5472.can-19-3911
Vancouver
Hilfenhaus G, Mompeón A, Freshman J, Prajapati DP, Hernandez G, Freitas VM, Ma F, Langenbacher AD, Mirkov S, Song D, Cho B-K, Goo YA, Pellegrini M, Chen J-N, Damoiseaux R, Arispe MLI. A high-content screen identifies drugs that restrict tumor cell extravasation across the Endothelial Barrier [Internet]. Cancer Research. 2021 ; 81( 3): 619-633.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/0008-5472.can-19-3911
Trabalho de evento-resumo periodico
Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic (2021)
Pimentel, Franklin Fernandes; Borba, Jéssica Maria Camargo; Rodrigues, Tamara Cristina Gomes Ferraz; Peruchi, Karoline P. I.; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Fonte: Cancer Research. Nome do evento: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, TERAPÊUTICA MÉDICA, COVID-19, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30. Acesso em: 10 nov. 2024. , 2021
APA
Pimentel, F. F., Borba, J. M. C., Rodrigues, T. C. G. F., Peruchi, K. P. I., Carrara, H. H. A., Andrade, J. M. de, & Reis, F. J. C. dos. (2021). Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS13-30
NLM
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Vancouver
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Trabalho de evento-resumo periodico
DUSP3-NPM-P53 axis: a new regulator ofgenomic stability of cells under genotoxic stress (2020)
Forti, Fabio Luis ; Russo, Lilian Cristina
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting. Unidade: IQ
Assuntos: PROTEÍNAS NUCLEARES, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORTI, Fabio Luis e RUSSO, Lilian Cristina. DUSP3-NPM-P53 axis: a new regulator ofgenomic stability of cells under genotoxic stress. Cancer Research. Philadelphia: American Association for Cancer Research (AACR). Disponível em: https://doi.org/10.1158/1538-7445.AM2020-2372. Acesso em: 10 nov. 2024. , 2020
APA
Forti, F. L., & Russo, L. C. (2020). DUSP3-NPM-P53 axis: a new regulator ofgenomic stability of cells under genotoxic stress. Cancer Research. Philadelphia: American Association for Cancer Research (AACR). doi:10.1158/1538-7445.AM2020-2372
NLM
Forti FL, Russo LC. DUSP3-NPM-P53 axis: a new regulator ofgenomic stability of cells under genotoxic stress [Internet]. Cancer Research. 2020 ; 80( 16):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2020-2372
Vancouver
Forti FL, Russo LC. DUSP3-NPM-P53 axis: a new regulator ofgenomic stability of cells under genotoxic stress [Internet]. Cancer Research. 2020 ; 80( 16):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2020-2372
Artigo de periodico
RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling (2020)
Loh, Xin-Yi; Sun, Qiao-Yang; Ding, Ling-Wen; Mayakonda, Anand; Venkatachalam, Nachiyappan; Yeo, Mei-Shi; Silva, Tiago Chedraoui ; Xiao, Jin-Fen; Doan, Ngan B.; Said, Jonathan W.; Ran, Xue-Bin; Zhou, Si-Qin; Dakle, Pushkar; Shyamsunder, Pavithra; Koh, Angele Pei-Fern; Huang, Ruby Yun-Ju; Berman, Benjamin P.; Tan, Soo-Yong; Yang, Henry; Lin, De-Chen; Koeffler, H. Phillip
Fonte: Cancer Research. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, CARCINOGÊNESE, CICLO CELULAR, ANÓXIA, LINHAGEM CELULAR, EXPRESSÃO GÊNICA, NEOPLASIAS DA BEXIGA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOH, Xin-Yi et al. RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling. Cancer Research, v. 80, n. 2, p. 219-233, 2020Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.CAN-18-2796. Acesso em: 10 nov. 2024.
APA
Loh, X. -Y., Sun, Q. -Y., Ding, L. -W., Mayakonda, A., Venkatachalam, N., Yeo, M. -S., et al. (2020). RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling. Cancer Research, 80( 2), 219-233. doi:10.1158/0008-5472.CAN-18-2796
NLM
Loh X-Y, Sun Q-Y, Ding L-W, Mayakonda A, Venkatachalam N, Yeo M-S, Silva TC, Xiao J-F, Doan NB, Said JW, Ran X-B, Zhou S-Q, Dakle P, Shyamsunder P, Koh AP-F, Huang RY-J, Berman BP, Tan S-Y, Yang H, Lin D-C, Koeffler HP. RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling [Internet]. Cancer Research. 2020 ; 80( 2): 219-233.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/0008-5472.CAN-18-2796
Vancouver
Loh X-Y, Sun Q-Y, Ding L-W, Mayakonda A, Venkatachalam N, Yeo M-S, Silva TC, Xiao J-F, Doan NB, Said JW, Ran X-B, Zhou S-Q, Dakle P, Shyamsunder P, Koh AP-F, Huang RY-J, Berman BP, Tan S-Y, Yang H, Lin D-C, Koeffler HP. RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling [Internet]. Cancer Research. 2020 ; 80( 2): 219-233.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/0008-5472.CAN-18-2796
Trabalho de evento-resumo periodico
Meningioma subgroups associated with functional genomic elements defined by DNA methylation (2019)
Malta, Tathiane Maistro; Snyder, James; Wells, Michael; Carvalho, Ana de; Poisson, Laila; Souza, Camila; Zadeh, Gelareh; Aldape, Kenneth; Tirapelli, Daniela Pretti da Cunha ; Carlotti Júnior, Carlos Gilberto ; Lee, Yan; Kalkanis, Steven; Walbert, Tobias; Noushmehr, Houtan
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: MENINGIOMA, DNA, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane Maistro et al. Meningioma subgroups associated with functional genomic elements defined by DNA methylation. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-841. Acesso em: 10 nov. 2024. , 2019
APA
Malta, T. M., Snyder, J., Wells, M., Carvalho, A. de, Poisson, L., Souza, C., et al. (2019). Meningioma subgroups associated with functional genomic elements defined by DNA methylation. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-841
NLM
Malta TM, Snyder J, Wells M, Carvalho A de, Poisson L, Souza C, Zadeh G, Aldape K, Tirapelli DP da C, Carlotti Júnior CG, Lee Y, Kalkanis S, Walbert T, Noushmehr H. Meningioma subgroups associated with functional genomic elements defined by DNA methylation [Internet]. Cancer Research. 2019 ; 79( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-841
Vancouver
Malta TM, Snyder J, Wells M, Carvalho A de, Poisson L, Souza C, Zadeh G, Aldape K, Tirapelli DP da C, Carlotti Júnior CG, Lee Y, Kalkanis S, Walbert T, Noushmehr H. Meningioma subgroups associated with functional genomic elements defined by DNA methylation [Internet]. Cancer Research. 2019 ; 79( 13):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-841
Trabalho de evento-resumo periodico
Non-invasive prediction of glioma tumor stemness using multimodal MRI (2019)
Davoodi-Bojd, Esmaeil; Malta, Tathiane; Griffith, Brent; Snyder, James; Walbert, Tobias; Noushmehr, Houtan ; Soltanian-Zadeh, Hamid
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: GLIOMA, TUMOR CARCINOIDE, RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVOODI-BOJD, Esmaeil et al. Non-invasive prediction of glioma tumor stemness using multimodal MRI. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-1939. Acesso em: 10 nov. 2024. , 2019
APA
Davoodi-Bojd, E., Malta, T., Griffith, B., Snyder, J., Walbert, T., Noushmehr, H., & Soltanian-Zadeh, H. (2019). Non-invasive prediction of glioma tumor stemness using multimodal MRI. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-1939
NLM
Davoodi-Bojd E, Malta T, Griffith B, Snyder J, Walbert T, Noushmehr H, Soltanian-Zadeh H. Non-invasive prediction of glioma tumor stemness using multimodal MRI [Internet]. Cancer Research. 2019 ; 79( 13): 1939.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1939
Vancouver
Davoodi-Bojd E, Malta T, Griffith B, Snyder J, Walbert T, Noushmehr H, Soltanian-Zadeh H. Non-invasive prediction of glioma tumor stemness using multimodal MRI [Internet]. Cancer Research. 2019 ; 79( 13): 1939.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1939
Trabalho de evento-resumo periodico
Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer (2019)
Abraham, Brian J.; Reddy, Jessica; Fonseca, Marcos Abraão de Souza ; Klein, Isaac A.; Afeyan, Lena K.; Corona, Rosario I.; Cejas, Paloma; Segato, Felipe; Karlan, Beth Y.; Gayther, Simon A.; Freedman, Matthew L.; Noushmehr, Houtan ; Brown, Myles; Matulonis, Ursula A.; Lawrenson, Kate; Yong, Richard A.
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: NEOPLASIAS OVARIANAS, GENÉTICA MÉDICA, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABRAHAM, Brian J. et al. Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-2615. Acesso em: 10 nov. 2024. , 2019
APA
Abraham, B. J., Reddy, J., Fonseca, M. A. de S., Klein, I. A., Afeyan, L. K., Corona, R. I., et al. (2019). Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-2615
NLM
Abraham BJ, Reddy J, Fonseca MA de S, Klein IA, Afeyan LK, Corona RI, Cejas P, Segato F, Karlan BY, Gayther SA, Freedman ML, Noushmehr H, Brown M, Matulonis UA, Lawrenson K, Yong RA. Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer [Internet]. Cancer Research. 2019 ; 79( 13): 2615.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-2615
Vancouver
Abraham BJ, Reddy J, Fonseca MA de S, Klein IA, Afeyan LK, Corona RI, Cejas P, Segato F, Karlan BY, Gayther SA, Freedman ML, Noushmehr H, Brown M, Matulonis UA, Lawrenson K, Yong RA. Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer [Internet]. Cancer Research. 2019 ; 79( 13): 2615.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-2615
Artigo de periodico
Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus (2019)
Buckley, Melissa A.; Woods, Nicholas T.; Tyrer, Jonathan P.; Mendoza-Fandino, Gustavo A.; Lawrenson, Kate ; Hazelett, Dennis J. ; Najafabadi, Hamed S. ; Gjyshi, Anxhela; Carvalho, Renato S.; Lyra Júnior, Paulo C.; Coetzee, Simon G. ; Shen, Howard C.; Yang, Ally W.; Earp, Madalene A.; Yoder, Sean J.; Risch, Harvey ; Chenevix-Trench, Georgia; Ramus, Susan J. ; Phelan, Catherine M.; Coetzee, Gerhard A.; Noushmehr, Houtan ; Hughes, Timothy R.; Sellers, Thomas A.; Goode, Ellen L.; Pharoah, Paul D.; Gayther, Simon A.; Monteiro, Alvaro N. A.
Fonte: Cancer Research. Unidade: FMRP
Assuntos: NEOPLASIAS OVARIANAS, MAPEAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUCKLEY, Melissa A. et al. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research, v. 79, n. 3, p. 467-481, 2019Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.CAN-17-3864. Acesso em: 10 nov. 2024.
APA
Buckley, M. A., Woods, N. T., Tyrer, J. P., Mendoza-Fandino, G. A., Lawrenson, K., Hazelett, D. J., et al. (2019). Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research, 79( 3), 467-481. doi:10.1158/0008-5472.CAN-17-3864
NLM
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandino GA, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra Júnior PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder SJ, Risch H, Chenevix-Trench G, Ramus SJ, Phelan CM, Coetzee GA, Noushmehr H, Hughes TR, Sellers TA, Goode EL, Pharoah PD, Gayther SA, Monteiro ANA. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus [Internet]. Cancer Research. 2019 ; 79( 3): 467-481.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/0008-5472.CAN-17-3864
Vancouver
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandino GA, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra Júnior PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder SJ, Risch H, Chenevix-Trench G, Ramus SJ, Phelan CM, Coetzee GA, Noushmehr H, Hughes TR, Sellers TA, Goode EL, Pharoah PD, Gayther SA, Monteiro ANA. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus [Internet]. Cancer Research. 2019 ; 79( 3): 467-481.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/0008-5472.CAN-17-3864
Trabalho de evento-resumo periodico
Expression of notch and nodal embryonic components in BRAF- and RAS-like thyroid cancer cell lines (2019)
Dantonio, Paola M. ; Fuziwara, Cesar Seigi ; Saito, Kelly Cristina ; Kimura, Edna Teruko
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting. Unidade: ICB
Assuntos: CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS DA TIREOIDE, CARCINOMA PAPILAR, GENÔMICA, EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE, CÉLULAS-TRONCO, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANTONIO, Paola M. et al. Expression of notch and nodal embryonic components in BRAF- and RAS-like thyroid cancer cell lines. Cancer Research. Philadelphia: American Association for Cancer Research. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-1164. Acesso em: 10 nov. 2024. , 2019
APA
Dantonio, P. M., Fuziwara, C. S., Saito, K. C., & Kimura, E. T. (2019). Expression of notch and nodal embryonic components in BRAF- and RAS-like thyroid cancer cell lines. Cancer Research. Philadelphia: American Association for Cancer Research. doi:10.1158/1538-7445.AM2019-1164
NLM
Dantonio PM, Fuziwara CS, Saito KC, Kimura ET. Expression of notch and nodal embryonic components in BRAF- and RAS-like thyroid cancer cell lines [Internet]. Cancer Research. 2019 ; 79[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1164
Vancouver
Dantonio PM, Fuziwara CS, Saito KC, Kimura ET. Expression of notch and nodal embryonic components in BRAF- and RAS-like thyroid cancer cell lines [Internet]. Cancer Research. 2019 ; 79[citado 2024 nov. 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1164

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Nome do evento

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos